Call Us
Call Us
08045803336
Streptase Drug

Streptase Drug

Product Details:

  • Assay International Units (IU) confirmed, per vial
  • Molecular Formula C990H1528N282O418S9 (approximate)
  • Physical Form Lyophilized powder for injection
  • Refractive Rate Not applicable (solid)
  • HS Code 300390
  • CAS No 9002-01-1
  • Solubility Soluble in water after reconstitution
  • Click to View more
X

Streptase Drug Price And Quantity

  • 1 Piece

Streptase Drug Product Specifications

  • International Units (IU) confirmed, per vial
  • C990H1528N282O418S9 (approximate)
  • Streptokinase, sterile excipients
  • Streptokinase (Thrombolytic agent)
  • Not applicable (solid)
  • Lyophilized powder for injection
  • 24 months from manufacture date
  • 300390
  • 9002-01-1
  • Soluble in water after reconstitution
  • 1 vial per box
  • White to off-white lyophilized cake
  • 99%
  • Store below 25C, protect from light
  • Not applicable (peptide/protein)
  • Not applicable (protein-based)
  • As directed by physician, typically dissolved before intravenous infusion
  • Rapid dissolution of blood clots in acute myocardial infarction, pulmonary embolism, and other thromboembolic disorders
  • Adults (not recommended for children)

Streptase Drug Trade Information

  • 15- 20 Piece Per Day
  • 15- 20 Days

Product Description

The streptase drug is a prescription medicine used to treat the symptoms of Acute Myocardial Infarction. Streptase may be used alone or with other medications. The Streptase (streptokinase) is an enzyme used in the treatment of heart attack or lung blood clots ( pulmonary embolism) as well as leg blood clots (deep venous thrombosis - DVT ). Streptase drug is used to dissolve blood clots that have formed in the blood vessels. It is used immediately after symptoms of a heart attack occur to improve patient survival.


Potent Thrombolytic Action

Streptase delivers efficient clot-dissolving effects using streptokinase, facilitating swift blood flow restoration in acute cardiovascular and thromboembolic conditions. Its high purity level guarantees reliable therapeutic performance, making it a preferred choice for medical professionals treating serious clot-related emergencies.


Easy Reconstitution and Administration

The lyophilized powder format of Streptase is quickly soluble in sterile water, allowing easy preparation for intravenous infusion. Dosage and infusion rates are determined by the treating physician based on individual patient needs, ensuring optimal safety and efficacy during hospital use.


Stringent Safety and Quality Protocols

Each vial of Streptase passes strict identity and sterility tests in accordance with WHO GMP guidelines. The product is packaged individually and should be stored below 25C, protected from light, to maintain its stability for up to 24 months from the manufacture date.

FAQ's of Streptase Drug:


Q: How is Streptase prepared and administered?

A: Streptase is supplied as a lyophilized powder that must be dissolved in sterile water before use. The reconstituted solution is then given as an intravenous infusion, with dosage tailored by a physician according to specific patient indications.

Q: What conditions is Streptase primarily used for?

A: Streptase is indicated mainly for the rapid treatment of acute myocardial infarction, deep vein thrombosis, and pulmonary embolism, facilitating the dissolution of dangerous blood clots in adult patients.

Q: When should Streptase not be used?

A: Streptase is contraindicated in patients with active internal bleeding, known bleeding disorders, or hypersensitivity to streptokinase. It is also not recommended for use in children.

Q: Where should Streptase be stored after purchase?

A: Streptase vials should be kept below 25C and protected from light to preserve the product's stability and shelf life, which is 24 months from the manufacture date.

Q: What is the main benefit of using Streptase for thromboembolic emergencies?

A: The major benefit of Streptase is its ability to rapidly dissolve blood clots, helping to restore circulation and reduce the extent of damage in life-threatening conditions such as heart attacks and pulmonary embolism.

Q: Is Streptase recognized for quality and safety?

A: Yes, Streptase is a WHO GMP-registered product that meets international standards for sterility and identity, ensuring reliable and safe clinical use.

Q: Who can prescribe and administer Streptase?

A: Streptase should only be prescribed and administered by qualified healthcare professionals in appropriate medical facilities due to its potent activity and specific clinical indications.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Cardio Vascular Drugs' category



Back to top